WILLIAM E. ROTE - 11 May 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Senior Vice President, R&D
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
11 May 2021
Net transactions value
-$60,312
Form type
4
Filing time
13 May 2021, 16:13:17 UTC
Next filing
17 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale $29,916 -1,563 -4.5% $19.14 33,269 11 May 2021 Direct F1
transaction TVTX Common Stock Sale $30,397 -1,562 -4.7% $19.46 31,707 12 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.